Cargando…

K-RAS Is…Complicated

Detalles Bibliográficos
Autor principal:	Clark, Geoffrey J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670387/ https://www.ncbi.nlm.nih.gov/pubmed/38001740 http://dx.doi.org/10.3390/cancers15225480

Ejemplares similares

E-cadherin and K-ras: implications of a newly developed model of gastric cancer
por: Till, Jacob E., et al.
Publicado: (2017)

Ras in epidermal proliferation
por: Drosten, Matthias, et al.
Publicado: (2014)

RasGrf1 and Aging
por: Davies, Kelvin J. A., et al.
Publicado: (2011)

Angiotensin II, RAS Activation, and RAS Blockers in COVID-19: Unambiguous Evidence
por: Calò, Lorenzo A., et al.
Publicado: (2022)

Tumorigenicity of RTK/RAS in urothelium
por: Wu, Xue-Ru, et al.
Publicado: (2015)

Killer K-Ras
por: Powell, Kendall
Publicado: (2006)

Brain RAS: Hypertension and Beyond
por: de Gasparo, Marc, et al.
Publicado: (2013)

S-nitrosylation of Ras in breast cancer
por: Marshall, Harvey E, et al.
Publicado: (2012)

RAS MAPK inhibitors deregulation in leukemia
por: Pasmant, Eric, et al.
Publicado: (2015)

Mutant K-Ras in Pancreatic Cancer: An Insight on the Role of Wild-Type N-Ras and K-Ras-Dependent Cell Cycle Regulation
por: Ferguson, Robert, et al.
Publicado: (2023)

The Distinct Conformational Dynamics of K-Ras and H-Ras A59G
por: Lukman, Suryani, et al.
Publicado: (2010)

Delivering a RAS protease halts tumor growth
por: Vidimar, Vania, et al.
Publicado: (2020)

Ras: structural details to guide direct targeting
por: Mattos, Carla
Publicado: (2015)

Arresting kinase suppressor of Ras in an inactive state
por: Badshah, Syed Lal, et al.
Publicado: (2017)

A perspective on the early days of RAS research
por: Weiss, Robin A.
Publicado: (2020)

Comparison of K-Ras and N-Ras Mutagenic Hot Spots for UVC Damage
por: Nair, Sindhu G., et al.
Publicado: (2019)

The RASSF1A Tumor Suppressor Binds the RasGAP DAB2IP and Modulates RAS Activation in Lung Cancer
por: Harrell Stewart, Desmond R., et al.
Publicado: (2020)

The 'RASor's' edge: Ras proteins and matrix destruction in arthritis
por: Schmucker, Adam C, et al.
Publicado: (2009)

Direct Modulators of K-Ras–Membrane Interactions
por: Morstein, Johannes, et al.
Publicado: (2023)

K-Ras Binds Calmodulin-Related Centrin1 with Potential Implications for K-Ras Driven Cancer Cell Stemness
por: Manoharan, Ganesh babu, et al.
Publicado: (2023)

Blocking K-Ras Interaction With the Plasma Membrane Is a Tractable Therapeutic Approach to Inhibit Oncogenic K-Ras Activity
por: Henkels, Karen M., et al.
Publicado: (2021)

A bacterial toxin that cleaves Ras oncoprotein
por: Biancucci, Marco, et al.
Publicado: (2015)

High-Affinity Interaction of the K-Ras4B Hypervariable Region with the Ras Active Site
por: Chavan, Tanmay S., et al.
Publicado: (2015)

Unveiling the Mysteries of RAS Signaling: A Journey of Discovery and Breakthroughs
por: Castellano, Esther
Publicado: (2023)

Direct Ras G12C inhibitors: crossing the rubicon
por: Lindsay, Colin R., et al.
Publicado: (2019)

Understanding and drugging RAS: 40 years to break the tip of the iceberg
por: Brady, Donita C., et al.
Publicado: (2022)

K-Ras protein as a drug target
por: McCormick, Frank
Publicado: (2016)

Modeling and subtleties of K-Ras and Calmodulin interaction
por: Garrido, Eduardo, et al.
Publicado: (2018)

The Relevance of Common K-RAS Gene Mutations and K-RAS mRNA Expression with Clinicopathological Findings and Survival in Breast Cancer
por: Kamian, Shaghayegh, et al.
Publicado: (2023)

Acute sensitivity of the oral mucosa to oncogenic K-ras
por: van der Weyden, Louise, et al.
Publicado: (2011)

Altered expression of Bcl-2, c-Myc, H-Ras, K-Ras, and N-Ras does not influence the course of mycosis fungoides
por: Maj, Joanna, et al.
Publicado: (2013)

mTORC1 regulates nutrient access in Ras-mediated tumors
por: Cheong, Heesun
Publicado: (2016)

K-Ras4A Plays a More Significant Role than K-Ras4B in Ductal Carcinoma of Breast
por: Mortazavipour, Mohamad Mahdi, et al.
Publicado: (2023)

Current Approaches in NSCLC Targeting K-RAS and EGFR
por: Aran, Veronica, et al.
Publicado: (2019)

K-Ras prenylation as a potential anticancer target
por: Baranyi, Marcell, et al.
Publicado: (2020)

Mutations of K-ras oncogene in human adrenal tumours in Taiwan.
por: Lin, S. R., et al.
Publicado: (1998)

An engineered protein antagonist of K-Ras/B-Raf interaction
por: Kauke, Monique J., et al.
Publicado: (2017)

Activated K-Ras and H-Ras display different interactions with saturable nonraft sites at the surface of live cells
por: Niv, Hagit, et al.
Publicado: (2002)

Restoration of mutant K-Ras repressed miR-199b inhibits K-Ras mutant non-small cell lung cancer progression
por: Jin, Hua, et al.
Publicado: (2019)

Molecular Analysis of Oncogenes, ras Family Genes (N‐ras, K‐ras, H‐ras), myc Family Genes (c‐myc, N‐myc) and mdm2 in Natural Killer Cell Neoplasms
por: Sugimoto, Kei‐ji, et al.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_aaqogcum76ilaeg323qle4k5l3